{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T13:02:06Z","timestamp":1785416526302,"version":"3.56.0"},"reference-count":35,"publisher":"American Society for Microbiology","issue":"12","license":[{"start":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T00:00:00Z","timestamp":1765324800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T00:00:00Z","timestamp":1765324800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2025,12,10]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>\n                      Ceftolozane\/tazobactam is widely used against extended-spectrum \u03b2-lactamase (ESBL)-producing Enterobacterales, yet FDA-approved dosing relies on intermittent infusion and a fixed 2:1 ratio that assumes adequate \u03b2-lactamase inhibition. Tazobactam\u2019s faster and variable clearance raises concerns for subtherapeutic exposure. This study evaluated whether continuous infusion (CI) improves pharmacokinetic target attainment and whether current dosing adequately covers both components. We conducted an analysis of 139 hospitalized adults receiving CI ceftolozane\/tazobactam with therapeutic drug monitoring (TDM). Free steady-state concentrations (\n                      <jats:italic toggle=\"yes\">f<\/jats:italic>\n                      Css) and observed clearance were calculated and assessed across kidney function strata. Population pharmacokinetic modeling and Monte Carlo simulations evaluated the probability of target attainment (PTA) for each drug. Despite kidney function-adjusted CI, 38.1% of patients had tazobactam\n                      <jats:italic toggle=\"yes\">f<\/jats:italic>\n                      Css &lt;4 mg\/L, a threshold linked to reduced efficacy and resistance emergence, while only 2.5% had ceftolozane\n                      <jats:italic toggle=\"yes\">f<\/jats:italic>\n                      Css &lt;8 mg\/L (namely 4\u00d7 MIC the Enterobacterales clinical breakpoint for susceptibility). Tazobactam clearance (mean 7.41 L\/h) was 2.5-fold higher than ceftolozane and highly variable (CV 115%). Kidney function explained only 23% of clearance variability. The cohort\u2019s older age (median 66 years; 26.6% \u226575 years) likely led to lower tazobactam clearance, suggesting even greater underexposure in younger patients. Simulations showed standard dosing achieved only 29%\u201354% cumulative response against ESBL-producing Enterobacterales, versus 73%\u201382% with optimized regimens using 2\u20133\u00d7 higher ceftolozane\/tazobactam doses of magnitude similar to those licensed for pneumonia. Current ceftolozane\/tazobactam dosing, even with CI, is often subtherapeutic for tazobactam. These findings challenge fixed-ratio formulations and support individualized, component-guided dosing to preserve efficacy and suppress resistance.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1128\/aac.01215-25","type":"journal-article","created":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T12:55:47Z","timestamp":1761742547000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":5,"title":["Keeping the horse with the cart: are we underdosing tazobactam even when using continuous-infusion ceftolozane\/tazobactam for effectively preventing resistance development by ESBL-producing Enterobacterales?"],"prefix":"10.1128","volume":"69","author":[{"given":"Manjunath P.","family":"Pai","sequence":"first","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00jmfr291","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Clinical Pharmacy, College of Pharmacy, University of Michigan","place":["Ann Arbor, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7135-4410","authenticated-orcid":true,"given":"Pier Giorgio","family":"Cojutti","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/01111rn36","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Medical and Surgical Sciences, Alma Mater Studiorum, University of Bologna","place":["Bologna, Italy"]},{"name":"Clinical Pharmacology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna","place":["Bologna, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3018-3779","authenticated-orcid":true,"given":"Milo","family":"Gatti","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/01111rn36","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Medical and Surgical Sciences, Alma Mater Studiorum, University of Bologna","place":["Bologna, Italy"]},{"name":"Clinical Pharmacology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna","place":["Bologna, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Rinaldi","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/01111rn36","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Medical and Surgical Sciences, Alma Mater Studiorum, University of Bologna","place":["Bologna, Italy"]},{"name":"Infectious Diseases Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna","place":["Bologna, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tommaso","family":"Tonetti","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/01111rn36","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Medical and Surgical Sciences, Alma Mater Studiorum, University of Bologna","place":["Bologna, Italy"]},{"name":"Anesthesiology and Intensive Care Medicine, IRCCS Azienda Ospedaliero-Universitaria di Bologna","place":["Bologna, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Siniscalchi","sequence":"additional","affiliation":[{"name":"Division of Anesthesiology, Department of Anesthesia and Intensive Care, IRCCS Azienda Ospedaliero-Universitaria di Bologna","place":["Bologna, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierluigi","family":"Viale","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/01111rn36","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Medical and Surgical Sciences, Alma Mater Studiorum, University of Bologna","place":["Bologna, Italy"]},{"name":"Infectious Diseases Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna","place":["Bologna, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6966-7167","authenticated-orcid":true,"given":"Federico","family":"Pea","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/01111rn36","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Medical and Surgical Sciences, Alma Mater Studiorum, University of Bologna","place":["Bologna, Italy"]},{"name":"Clinical Pharmacology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna","place":["Bologna, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.14.4.933-951.2001"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1093\/jacamr\/dlac048"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02318-20"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.395"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01566-16"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01265-19"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2023.106717"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiac.2018.11.005"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(17)30615-1"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2024.9803"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1002\/phar.2842"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-024-05139-z"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.18234"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-024-04911-5"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1080\/23744235.2024.2387130"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.00892-22"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1002\/phar.70019"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1002\/phar.2210"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajhp\/zxae317"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02635-15"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00727-15"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-90762-1"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgar.2023.01.003"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00160-19"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1097\/FTD.0000000000001236"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1002\/phar.1609"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2102953"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.7326\/M20-4366"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1159\/000180580"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1002\/j.1875-9114.2012.01108.x"},{"key":"e_1_3_3_32_2","volume-title":"Abstr P2225. Abstr Eur Congr Clin Microbiol Infect Dis","author":"Caro L","year":"2018","unstructured":"Caro L, Larson K, Nicolau D, Waele J, Kuti J, Saralaya R, Gadzicki E, Adedoyin A, Zeng Z, Rhee E. 2018. Lung penetration and PK\/PD attainment in pulmonary epithelial lining fluid (ELF) following 3g administration of ceftolozane\/tazobactam (TOL\/TAZ) to ventilated, critically-ill patients. Abstr P2225. Abstr Eur Congr Clin Microbiol Infect Dis. Madrid, Spain"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1097\/FTD.0000000000001334"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1128\/aac.01404-23"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkae290"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dki079"}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/aac.01215-25","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/aac.01215-25","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T14:05:39Z","timestamp":1765375539000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/aac.01215-25"}},"subtitle":[],"editor":[{"given":"James E.","family":"Leggett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,12,10]]},"references-count":35,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12,10]]}},"alternative-id":["10.1128\/aac.01215-25"],"URL":"https:\/\/doi.org\/10.1128\/aac.01215-25","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,10]]},"assertion":[{"value":"2025-08-06","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-25","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-29","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e01215-25"}}